Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5
Related Experiment Video
Updated: Dec 30, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
1Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health & Science University, Portland, Oregon 97201, USA.
Abstract:
The oncoprotein MDM2 associates with ribosomal proteins L5, L11, and L23. Both L11 and L23 have been shown to activate p53 by inhibiting MDM2-mediated p53 suppression. Here we have shown that L5 also activates p53. Overexpression of L5 stabilized ectopic p53 in H1299 cells and endogenous p53 in U2OS cells. Consequently, L5 enhanced p53 transcriptional activity and induced p53-dependent G1 cell cycle arrest. Furthermore, like L11 and L23, L5 also remarkably inhibited MDM2-mediated p53 ubiquitination. The interaction of L5 with MDM2 was also enhanced by treatment with a low dose of actinomycin D. Actinomycin D-induced p53 was inhibited by small interference RNA against L5. By reciprocal co-immunoprecipitation, we further showed that there were at least two MDM2-ribosomal protein complexes in cells: MDM2-L5-L11-L23 and p53-MDM2-L5-L11-L23. We propose that the MDM2-L5-L11-L23 complex functions to inhibit MDM2-mediated p53 ubiquitination and thus activates p53.
Insights
Ribosomal protein L5 activates the tumor suppressor p53 by inhibiting MDM2. This interaction stabilizes p53, enhances its activity, and induces cell cycle arrest, revealing a new p53 regulatory pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The oncoprotein MDM2 negatively regulates the tumor suppressor p53.
- Ribosomal proteins L11 and L23 are known to activate p53 by inhibiting MDM2.
- The role of ribosomal protein L5 in p53 regulation was previously unclear.
Purpose of the Study:
- To investigate the role of ribosomal protein L5 in the regulation of p53.
- To elucidate the mechanism by which L5 affects p53 stability and activity.
- To identify the molecular complexes involved in L5-mediated p53 activation.
Main Methods:
- Overexpression studies in H1299 and U2OS cells to assess p53 stabilization and transcriptional activity.
- Ubiquitination assays to evaluate the effect of L5 on MDM2-mediated p53 ubiquitination.
- Co-immunoprecipitation experiments to identify protein complexes involving MDM2, L5, and p53.
- Small interference RNA (siRNA) knockdown to confirm L5's role in actinomycin D-induced p53 activation.
Main Results:
- Overexpression of L5 stabilized both ectopic and endogenous p53.
- L5 enhanced p53 transcriptional activity, leading to p53-dependent G1 cell cycle arrest.
- L5 inhibited MDM2-mediated p53 ubiquitination, similar to L11 and L23.
- Actinomycin D treatment enhanced L5-MDM2 interaction, and L5 knockdown abrogated actinomycin D-induced p53 stabilization.
- Two distinct complexes were identified: MDM2-L5-L11-L23 and p53-MDM2-L5-L11-L23.
Conclusions:
- Ribosomal protein L5 is a novel activator of p53.
- L5 functions by inhibiting MDM2-mediated p53 ubiquitination, thereby stabilizing p53.
- The MDM2-L5-L11-L23 complex plays a critical role in p53 activation and tumor suppression.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
MicroRNAs
MicroRNAs

